NSECertificate under SEBI (Depositories and Participants) Regulations, 20185 Oct 2026 · 5 Oct 2026, 05:45 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Symbiotec Pharmalab Limited · SYMBIOTEC

✦ AI Summary

Symbiotec Pharmalab Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Symbiotec Pharmalab Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026

Attachments (1)

📄

SYMBIOTEC_05102026174444_ComplianceCertirficate__74_5_ofDPRegulation_.pdf

pdf

Download →
View document text
October 05, 2026 To, To, BSE Limited, National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Mumbai – 400001 Bandra (East), Mumbai – 400051 Scrip code: 544889 Symbol: SYMBIOTEC Sub: Certificate pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 Dear Sir/ Madam, Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby enclose certificate received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent of the Company, for the quarter ended September 30, 2026. The aforesaid information is also being made available on the Company's website i.e. https://investor.symbiotec.com/announcements Kindly take the same on record. Thanking you, For Symbiotec Pharmalab Limited Salil Jain Company Secretary & Compliance Officer Encl.: As above Registered Office & Works: Symbiotec Pharmalab Limited (Formerly known as Symbiotec Pharmalab Pvt. Ltd.) 385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222, Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com CIN: U24232MP2002PLC015293 MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) CIN: U67190MH1999PTC118368 Registered Address: C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083. Tel: +91 22 4918 6000 www.in.mpms.mufg.com Date : 03-10-2026 The Compliance Officer/ Company Secretary SYMBIOTEC PHARMALAB LIMITED 385/2, PIGDAMBER, RAU MHOW, INDORE MADHYA PRADESH INDORE PINCODE : 453331 Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Dear Sir/Madam, In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended 30th September 2026, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security certificates received were mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) Ashok Shetty Sr. Vice President-Corporate Registry MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services